Navigation Links
Scientist Warns Industry Not to Ignore Potential Health Threat to Pharmacy Workers
Date:11/10/2008

- Recently issued study that found retail pharmacy workers are exposed to

airborne pharmaceutical agents needs further review -

DREXEL, Mo., Nov. 10 /PRNewswire/ -- AlburtyLab's President, David Alburty issued a statement today regarding serious concerns about efforts by McKesson/Parata to misrepresent and diminish the potential health threats that pharmacy workers face when they work in pharmacies using air pressure driven dispensing machines.

Statement by David Alburty:

Communications recently issued by McKesson/Parata regarding potential exposure of pharmacy workers to airborne pill dust when they use air pressure driven drug dispensing machines attempt to mask a potentially serious health matter affecting pharmacy workers.

McKesson/Parata claims that unreleased tests they performed, not conducted by Occupational Safety and Health Administration (OSHA) but "under OSHA standards (set by *1 NIOSH)," are relevant to this issue. They are not.

It is critical to know that OSHA air quality regulations are limited to general guidelines for "nuisance dust" such as emissions from grinding and burning processes. There are no OSHA standards establishing safe quantities of pharmaceutical compounds in the air. Nor are there OSHA standards for PM-2.5 particles and nanoparticles. These very small particles, which are used to transport pharmaceutical agents, have been shown to be generated when pills are subjected to air pressure dispensing.

PM-2.5 particles are the subject of EPA air quality standards and World Health Organization guidelines because they penetrate the lungs deeply and rapidly enter the bloodstream. As documented in our (AlburtyLab, October 2008) study, these particles are believed to cause a number of serious health problems. The fact that OSHA standards do not yet address this issue does not mean that it should be ignored.

Our study unveiled potentially serious exposures for pharmacy workers, and our strong recommendation is that the issue needs to be studied by federal regulatory agencies. As reported by the publication Inside OSHA on October 27, 2008, "A NIOSH official says that he believes pharmacists are being exposed to harmful particles." He further stated, "The agency advises against using technology that produces any type of particulate that could be inhaled."

The official described our study as "fairly straightforward" and said that there is concern that drugs involved were "not meant to be inhaled."

Clearly, federal regulatory agencies must assess risk and set guidelines for these types of machines and establish procedures to monitor the health impact on pharmacy workers when they are used.

The previous press release, the executive summary and the full study are available for review.

http://www.alburtylab.com

About AlburtyLab, Inc.

AlburtyLab is an independent laboratory located in Drexel, Missouri that serves the aerosol research, development, and instrumentation communities. AlburtyLab has conducted independent studies for a range of agencies and companies, including Boeing/US Navy, Boston Scientific, Northrop Grumman, US Postal Service, US Department of Homeland Security, and the US Army Research Laboratory.

Technical questions may be directed to Mr. Alburty at (816) 619-3374 or via email to dalburty@alburtylab.com.

This study was funded by one of the technologies reviewed in the evaluation, ScriptPro LLC of Mission, Kansas.

The Executive Summary and the final report can be found at http://www.alburtylab.com

*1 NIOSH (National Institute of Occupational Safety and Health) that created testing specifications required by OSHA.

Contact: Josh Fenton, The Fenton Group

Tel. 401-490-4888/401-497-0186

jfenton@thefentongroup.net


'/>"/>
SOURCE AlburtyLab, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. New prion protein discovered by Canadian scientists may offer insight into mad cow disease
2. Scientists Probe Sepsis Deadly Secrets
3. Scientists puzzled by severe allergic reaction to cancer drug in the middle Southern US
4. Scientists Develop Natural Protection for Stored Foods
5. Scientists detect presence of marburg virus in african fruit bats
6. Scientists Spot Brains Free Will Center
7. Scientists ID Likely Culprit in Popcorn Lung
8. Scientists explain how insulin secreting cells maintain their glucose sensitivity
9. Scripps Research scientists shed new light on how antibodies fight HIV
10. Scientists, physicians present latest findings in personalized cancer treatment and prevention
11. Scientists demonstate link between genetic variant and effectiveness of smoking cessation meds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2016)... ... 2016 , ... TLC Laser Eye Centers announced today that it has acquired ... now be called “Gordon Schanzlin New Vision Institute, a TLC Laser Eye Center.” ... to ensure that patients continue to receive the highest quality of care. In addition, ...
(Date:5/5/2016)... ... May 05, 2016 , ... LELO has ... Every day, LELO fans reach out via email, social media and on the Volonté ... up: “Is the way I masturbate ‘normal’ or ‘correct’?” , While some methods are ...
(Date:5/5/2016)... ... May 05, 2016 , ... Michael Lanteri Agency in Fort ... assist the people of their local community. The agency pledges to select a ... Their hope is to bring awareness to important local causes with fundraising and ...
(Date:5/5/2016)... ... 2016 , ... Vitenas Cosmetic Surgery has been named as one of the ... of Architects and the Academy of Architecture for Health. The building, brainchild of founder ... to patients in October of 2014. , The prestigious Healthcare Design ...
(Date:5/5/2016)... ... May 05, 2016 , ... Sun Health registered ... the organization’s successful Care Transitions program at the 9th Annual Orthopedic ... “Minimizing Costs in the Post-Acute Environment Through Effective Transitions of Care.” , Major ...
Breaking Medicine News(10 mins):
(Date:5/4/2016)... According to market research "Global Computed ... to 2022 - Industry Insights by Slice Type (High, Mid ... by P&S Market Research, the global computed tomography market ... is expected to grow at a CAGR of 5.0% during ... is expected to witness the faster growth, CAGR of 5.3%, ...
(Date:5/4/2016)... Jersey , May 4, 2016 ... successful completion of an alternative public offering (APO). This ... owned operating company, Valeritas, Inc. and a private placement ... stock at $5.00 per share. Under the ... May 3, 2016, Valeritas Holdings, Inc. will trade on ...
(Date:5/4/2016)... DUBLIN , May 4, 2016 /PRNewswire/ ... the addition of the  "Global Acute Myeloid ... 2016"  report to their offering.  ... ,Global Acute Myeloid Leukemia Market and Competitive ... Acute Myeloid Leukemia pipeline products, Acute Myeloid ...
Breaking Medicine Technology: